Arizona Diagnostic Radiology’s Post

82% of eligible individuals are choosing not to undergo potentially life-saving lung cancer screening, according to a new study released by the American Cancer Society. Lung cancer is the country's leading cause of cancer-related deaths, with most cases not caught until a late stage when the survival rate is only 8%. When identified early, lung cancer is treatable. As early stages are largely symptom-free, its essential to follow ACS recommendation for annual screenings. Learn more about annual lung cancer screenings: https://bit.ly/4b6Df58

METASTATIC CANCER Metastatic cancer refers to cancer that has spread beyond the point of origin to other distant areas of the body. Metastasis is a word used to describe the spread of cancer. Unlike normal cells, cancer cells have the ability to grow outside of the place in your body where. they originated. When this happens, it's called metastatic cancer, advanced cancer or Stage IV cancer. The most common sites for cancers to metastasize include the lungs, liver, bones and brain. Other places include the adrenal gland, lymph nodes, skin and other organs. Some people will have minimal or no symptoms of metastatic cancer. In most cases, metastatic cancer is not curable. However, treatment can slow growth and ease many of the associated symptoms. #snsinstitutions #snsdesignthinking #snsdesignthinkers

According to the American Cancer Society, Lung Cancer is the Leading Cause of Cancer Death in the United States. 🫁 About 80% of lung cancer deaths are thought to result from smoking 🫁 Lung Cancer accounts for about 1 in 5 of all cancer deaths 🫁 Screening with low-dose CT can help detect lung cancer at its earliest stage, resulting in better outcomes Low-Dose CT is a quick and painless screening tool that uses low doses of radiation, comparable to a mammogram, to make detailed images of your lungs. These images are used to detect lung cancer at its earliest stages. https://lnkd.in/gmHkqEVN

Other than skin cancer, prostate cancer is the most common cancer in American men. The American Cancer Society’s estimates for prostate cancer in the United States for 2024 are: 🔹 About 299,010 new cases of prostate cancer 🔹 About 35,250 deaths from prostate cancer Prostate cancer can be a serious disease, but most men diagnosed with prostate cancer do not die from it. In fact, more than 3.1 million men in the United States who have been diagnosed with prostate cancer at some point are still alive today. Visit https://lnkd.in/enm5nfGU to learn more about prostate cancer.

According to the American Cancer Society, Lung Cancer is the Leading Cause of Cancer Death in the United States. 🫁 About 80% of lung cancer deaths are thought to result from smoking 🫁 Lung Cancer accounts for about 1 in 5 of all cancer deaths 🫁 Screening with low-dose CT can help detect lung cancer at its earliest stage, resulting in better outcomes Low-Dose CT is a quick and painless screening tool that uses low doses of radiation, comparable to a mammogram, to make detailed images of your lungs. These images are used to detect lung cancer at its earliest stages. https://lnkd.in/gmHkqEVN

DYK: 82 percent of eligible individuals are choosing not to undergo potentially life-saving lung cancer screening, according to a new study released by the American Cancer Society (ACS). Lung cancer is the country's leading cause of cancer-related deaths, with most cases not caught until a late stage when the survival rate is only 8%. When identified early, lung cancer is treatable. As early stages are largely symptom-free, its essential to follow ACS recommendation for annual screenings. Learn more about annual lung cancer screenings: https://bit.ly/3VuoPWJ

According to the American Cancer Society, Lung Cancer is the Leading Cause of Cancer Death in the United States. 🫁 About 80% of lung cancer deaths are thought to result from smoking 🫁 Lung Cancer accounts for about 1 in 5 of all cancer deaths 🫁 Screening with low-dose CT can help detect lung cancer at its earliest stage, resulting in better outcomes Low-Dose CT is a quick and painless screening tool that uses low doses of radiation, comparable to a mammogram, to make detailed images of your lungs. These images are used to detect lung cancer at its earliest stages. https://lnkd.in/gmHkqEVN

DYK: 82 percent of eligible individuals are choosing not to undergo potentially life-saving lung cancer screening, according to a new study released by the American Cancer Society (ACS). Lung cancer is the country's leading cause of cancer-related deaths, with most cases not caught until a late stage when the survival rate is only 8%. When identified early, lung cancer is treatable. As early stages are largely symptom-free, its essential to follow ACS recommendation for annual screenings. Learn more about annual lung cancer screenings: https://lnkd.in/gt8E7S7p

November is Lung Cancer Awareness Month Lung cancer is the second most common cancer worldwide, yet many cases are preventable and treatable with early detection. At Predicine, we’re committed to advancing the fight against lung cancer through groundbreaking precision diagnostics and innovative treatments. Lung cancer remains one of the leading causes of cancer-related deaths, but together we can make a difference by promoting awareness and early detection. Discover how Predicine’s liquid biopsy technology is revolutionizing personalized lung cancer care by informing treatment decisions and revealing resistance mechanisms through groundbreaking research: The prospective real-world study of high-dose Furmonertinib in patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastases: https://lnkd.in/gsNd5eM4    #NSCLC #lungcancer #awareness #Predicine #liquidbiopsy #precisionmedicine 

Hot Topic of the Week: Cancer Dormancy. Cancer dormancy is a critical stage in the development of cancer. At this stage, cancer cells are essentially in a dormant state and do not actively proliferate, but remain viable and metabolically active. This dormant state can persist for months or even years, during which the cancer is often clinically undetectable. Understanding cancer dormancy is crucial because dormant cancer cells can be reactivated by internal or external factors, leading to cancer recurrence and metastasis.